Lowell Blake & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.15M | Buy |
34,610
+5,048
| +17% | +$459K | 0.89% | 28 |
|
|
2023
Q2 | $2.39M | Sell |
29,562
-14
| -0% | -$1.13K | 0.69% | 28 |
|
|
2023
Q1 | $2.35M | Buy |
29,576
+1,734
| +6% | +$138K | 0.73% | 29 |
|
|
2022
Q4 | $1.88M | Hold |
27,842
| – | – | 0.63% | 30 |
|
|
2022
Q3 | $1.39M | Buy |
27,842
+788
| +3% | +$39.3K | 0.54% | 31 |
|
|
2022
Q2 | $1.51M | Sell |
27,054
-400
| -1% | -$22.3K | 0.58% | 32 |
|
|
2022
Q1 | $1.52M | Buy |
27,454
+3,580
| +15% | +$199K | 0.57% | 33 |
|
|
2021
Q4 | $1.34M | Sell |
23,874
-5,100
| -18% | -$286K | 0.52% | 33 |
|
|
2021
Q3 | $1.39M | Buy |
28,974
+1,000
| +4% | +$48K | 0.65% | 35 |
|
|
2021
Q2 | $1.17M | Buy |
27,974
+2,962
| +12% | +$124K | 0.54% | 37 |
|
|
2021
Q1 | $843K | Buy |
25,012
+17,138
| +218% | +$578K | 0.43% | 38 |
|
|
2020
Q4 | $275K | Buy |
7,874
+122
| +2% | +$4.26K | 0.2% | 38 |
|
|
2020
Q3 | $269K | Sell |
7,752
-372
| -5% | -$12.9K | 0.22% | 46 |
|
|
2020
Q2 | $266K | Buy |
8,124
+624
| +8% | +$20.4K | 0.25% | 43 |
|
|
2020
Q1 | $226K | Hold |
7,500
| – | – | 0.29% | 46 |
|
|
2019
Q4 | $217K | Buy |
+7,500
| New | +$217K | 0.24% | 56 |
|